Concepedia

Linda R. Weinberg

LR

Statistics

Publications

6

Citations

210

H-Index

6

Active since

2005

Affiliations

Avalon Pharma (United States)(Current)

Linda R. Weinberg is an author at Avalon Pharma (United States) specializing in enzyme inhibition, pharmacology, and drug discovery.

ORCID

Publications per year

2005–2011

6

Publications

6

Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells

Weihua Wan, Mark S. Albom, Lihui Lü et al. · Blood · 2005 · 105 citations

, , +11

Synthesis and structure–activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase

Karen L. Milkiewicz, Linda R. Weinberg, Mark S. Albom et al. · Bioorganic & Medicinal Chemistry · 2010 · 30 citations · Full text

, , +14

Fused bicyclic derivatives of 2,4-diaminopyrimidine as c-Met inhibitors

Linda R. Weinberg, Mark S. Albom, Thelma S. Angeles et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 23 citations · Full text

, , +13

2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: Modification of target structure to minimize reactive metabolite formation

Linda R. Weinberg, Mark S. Albom, Thelma S. Angeles et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 19 citations · Full text

, , +13

Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases

Craig A. Zificsak, Diane E. Gingrich, Henry J. Breslin et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 19 citations · Full text

, , +16

1–5 of 6